Home > Press > H&HGroup invests $2.8M in Evolved Nanomaterial Sciences
Harris & Harris Group invests $2,800,000 in Evolved Nanomaterial Sciences, Inc.
Posted on March 09, 2006
Harris & Harris Group, Inc., announced today that it led a
$3,300,000 Series A round of financing of privately held Evolved
Nanomaterial Sciences, Inc. (ENS) of Cambridge, MA. Harris &
Harris Group invested $2,800,000 in this round of financing.
ENS has developed a number of nanotechnology-enhanced approaches for
the resolution of chiral molecules. ENS is using its proprietary
ESPTM technology to manufacture high-capacity, high-generality HPLC
columns that simplify chiral method development and chiral
chromatography and purification. The A round funding will be used
to fill out its manufacturing and product development capabilities
and to support the launch of its first line of commercially
Harris & Harris Group is a publicly traded venture capital company
that now makes initial investments exclusively in tiny technology,
including nanotechnology, microsystems and microelectromechanical
systems (MEMS). The Company's last 27 initial private equity
investments have been in tiny technology-enabled companies. The
Company has 20,756,345 common shares outstanding.
Detailed information about Harris & Harris Group and its holdings
can be found on its website at www.TinyTechVC.com.
Copyright © Harris & Harris Group
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015
A first glimpse inside a macroscopic quantum state March 28th, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015
Designer's toolkit for dynamic DNA nanomachines: Arm-waving nanorobot signals new flexibility in DNA origami March 27th, 2015
Using magnetic fields to understand high-temperature superconductivity: Los Alamos explores experimental path to potential 'next theory of superconductivity' March 27th, 2015